https://www.selleckchem.com/pr....oducts/nec-1s-7-cl-o
ith intrathoracic NSGCT metastases. Aggressive surgical management should be considered for all residual disease due to the low concordance between sites and the potential for excellent long-term survival even in patients with chemotherapy-refractory disease. High-dose nitric oxide (NO) has been shown effective against a variety of micro-organisms invitro, including common bacteria found in donor organs. However, clinical obstacles related to its implementation invivo are the formation of methemoglobin and the accumulation of